Demand for AYUSH products has increased three-fold during coronavirus pandemic: Shripad Yesso Naik

▴ Demand for AYUSH products has increased three-fold during coronavirus pandemic: Shripad Yesso Naik
The Minister said, Amid the Covid-19 crisis, our ayurvedic medicines have been used in as many as 100 countries as an immunity booster and is slowly gaining momentum across the world.

AYUSH minister Shripad Yesso Naik has said, the demand for AYUSH products has increased three-fold during the coronavirus pandemic.

The Minister said, Amid the Covid-19 crisis, our ayurvedic medicines have been used in as many as 100 countries as an immunity booster and is slowly gaining momentum across the world. He was speaking at the inaugural function of two new departments of Central Ayurveda Research Institute in Jhansi.
 

The two buildings inaugurated by the Minister have been built under an estimated budget of 14 crore rupees, and as per the guidelines of the World Health Organization (WHO). AIR correspondent reports, these departments house a national raw drug repository, a pharmacy, and a drug-testing laboratory which will also help in employment generation in the Bundelkhand region of the state which is full of medicinal plants.

 


A first of its kind in the country, the repository will have 500 varieties of medicinal plant samples to be used for research purposes. Similarly, the pharmacy department will be used for advanced research of new variants of ayurvedic medicines which can be lab tested and undergone clinical trials here itself.
 
The research done in the institute will be further shared across the country in order to promote ayurvedic medicines. OPD at the institute would soon start functioning here. On the occasion of Union, AYUSH Minister Shripad Yasso Naik said that during the COVID pandemic AYUSH medicines became very popular.

Tags : #India #AyushProducts #CoronaVirusPandemic #AyushMinister #ShripadYessoNaik #AyurvedicMedicines #ImmunityBooster #CentralAyurvedaResearchInstitute #WHO #FightAgainstCovid-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024